Literature DB >> 23719551

Circulating and dietary magnesium and risk of cardiovascular disease: a systematic review and meta-analysis of prospective studies.

Liana C Del Gobbo1, Fumiaki Imamura, Jason H Y Wu, Marcia C de Oliveira Otto, Stephanie E Chiuve, Dariush Mozaffarian.   

Abstract

BACKGROUND: Clinical hypomagnesemia and experimental restriction of dietary magnesium increase cardiac arrhythmias. However, whether or not circulating or dietary magnesium at usual concentrations or intakes influences the risk of cardiovascular disease (CVD), including fatal ischemic heart disease (IHD), is unclear.
OBJECTIVE: We performed a systematic review and meta-analysis to investigate prospective associations of circulating and dietary magnesium with incidence of CVD, IHD, and fatal IHD.
DESIGN: Multiple literature databases were systematically searched without language restriction through May 2012. Inclusion decisions and data extraction were performed in duplicate. Linear dose-response associations were assessed by using random-effects meta-regression. Potential nonlinear associations were evaluated by using restricted cubic splines.
RESULTS: Of 2303 articles, 16 studies met the eligibility criteria; these studies comprised 313,041 individuals and 11,995 CVD, 7534 IHD, and 2686 fatal IHD events. Circulating magnesium (per 0.2 mmol/L increment) was associated with a 30% lower risk of CVD (RR: 0.70; 95% CI: 0.56, 0.88 per 0.2 mmol/L) and trends toward lower risks of IHD (RR: 0.83; 95% CI: 0.75, 1.05) and fatal IHD (RR: 0.61; 95% CI: 0.37, 1.00). Dietary magnesium (per 200-mg/d increment) was not significantly associated with CVD (RR: 0.89; 95% CI: 0.75, 1.05) but was associated with a 22% lower risk of IHD (RR: 0.78; 95% CI: 0.67, 0.92). The association of dietary magnesium with fatal IHD was nonlinear (P < 0.001), with an inverse association observed up to a threshold of ∼250 mg/d (RR: 0.73; 95% CI: 0.62, 0.86), compared with lower intakes.
CONCLUSION: Circulating and dietary magnesium are inversely associated with CVD risk, which supports the need for clinical trials to evaluate the potential role of magnesium in the prevention of CVD and IHD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23719551      PMCID: PMC3683817          DOI: 10.3945/ajcn.112.053132

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  40 in total

1.  Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.

Authors:  Y Song; K He; E B Levitan; J E Manson; S Liu
Journal:  Diabet Med       Date:  2006-10       Impact factor: 4.359

2.  Evaluation of the quality of prognosis studies in systematic reviews.

Authors:  Jill A Hayden; Pierre Côté; Claire Bombardier
Journal:  Ann Intern Med       Date:  2006-03-21       Impact factor: 25.391

3.  Bias in meta-analysis detected by a simple, graphical test.

Authors:  M Egger; G Davey Smith; M Schneider; C Minder
Journal:  BMJ       Date:  1997-09-13

4.  Dietary magnesium intake and risk of cardiovascular disease among women.

Authors:  Yiqing Song; JoAnn E Manson; Nancy R Cook; Christine M Albert; Julie E Buring; Simin Liu
Journal:  Am J Cardiol       Date:  2005-08-29       Impact factor: 2.778

5.  Dietary magnesium intake and risk of incident hypertension among middle-aged and older US women in a 10-year follow-up study.

Authors:  Yiqing Song; Howard D Sesso; JoAnn E Manson; Nancy R Cook; Julie E Buring; Simin Liu
Journal:  Am J Cardiol       Date:  2006-10-23       Impact factor: 2.778

6.  Zinc, copper, and magnesium and risks for all-cause, cancer, and cardiovascular mortality.

Authors:  Nathalie Leone; Dominique Courbon; Pierre Ducimetiere; Mahmoud Zureik
Journal:  Epidemiology       Date:  2006-05       Impact factor: 4.822

7.  Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  F Liao; A R Folsom; F L Brancati
Journal:  Am Heart J       Date:  1998-09       Impact factor: 4.749

8.  Serum magnesium and ischaemic heart disease: findings from a national sample of US adults.

Authors:  E S Ford
Journal:  Int J Epidemiol       Date:  1999-08       Impact factor: 7.196

Review 9.  Regulation of cation channels in cardiac and smooth muscle cells by intracellular magnesium.

Authors:  Kanigula Mubagwa; Asfree Gwanyanya; Sergey Zakharov; Regina Macianskiene
Journal:  Arch Biochem Biophys       Date:  2006-11-10       Impact factor: 4.013

10.  Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women.

Authors:  Forrest H Nielsen; David B Milne; Leslie M Klevay; Sandra Gallagher; LuAnn Johnson
Journal:  J Am Coll Nutr       Date:  2007-04       Impact factor: 3.169

View more
  108 in total

1.  Proton pump inhibitors use in hemodialysis patients and serum magnesium levels.

Authors:  Emre Erdem
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Dietary magnesium intake and fracture risk: data from a large prospective study.

Authors:  Nicola Veronese; Brendon Stubbs; Marco Solmi; Marianna Noale; Alberto Vaona; Jacopo Demurtas; Stefania Maggi
Journal:  Br J Nutr       Date:  2017-06-20       Impact factor: 3.718

3.  Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come.

Authors:  Rebecca B Costello; Ronald J Elin; Andrea Rosanoff; Taylor C Wallace; Fernando Guerrero-Romero; Adela Hruby; Pamela L Lutsey; Forrest H Nielsen; Martha Rodriguez-Moran; Yiqing Song; Linda V Van Horn
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

4.  Serum magnesium, phosphorus, and calcium levels and subclinical calcific aortic valve disease: A population-based study.

Authors:  Takashi Hisamatsu; Katsuyuki Miura; Akira Fujiyoshi; Aya Kadota; Naoko Miyagawa; Atsushi Satoh; Maryam Zaid; Takashi Yamamoto; Minoru Horie; Hirotsugu Ueshima
Journal:  Atherosclerosis       Date:  2018-03-22       Impact factor: 5.162

5.  Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.

Authors:  Jiachuan Xiong; Ting He; Min Wang; Ling Nie; Ying Zhang; Yiqin Wang; Yunjian Huang; Bing Feng; Jingbo Zhang; Jinghong Zhao
Journal:  J Nephrol       Date:  2019-03-19       Impact factor: 3.902

6.  Serum magnesium and risk of new onset heart failure in men: the Kuopio Ischemic Heart Disease Study.

Authors:  Setor K Kunutsor; Hassan Khan; Jari A Laukkanen
Journal:  Eur J Epidemiol       Date:  2016-05-25       Impact factor: 8.082

7.  Association of magnesium in serum and urine with carotid intima-media thickness and serum lipids in middle-aged and elderly Chinese: a community-based cross-sectional study.

Authors:  Yi Cao; Cheng Wang; Ke Guan; Ying Xu; Yi-xiang Su; Yu-ming Chen
Journal:  Eur J Nutr       Date:  2015-03-07       Impact factor: 5.614

8.  Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials.

Authors:  Huilin Tang; Xi Zhang; Jingjing Zhang; Yufeng Li; Liana C Del Gobbo; Suodi Zhai; Yiqing Song
Journal:  Diabetologia       Date:  2016-09-15       Impact factor: 10.122

Review 9.  Clinical features of CKD-MBD in Japan: cohort studies and registry.

Authors:  Takayuki Hamano; Yusuke Sakaguchi; Naohiko Fujii; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2016-12-09       Impact factor: 2.801

Review 10.  Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review.

Authors:  Dariush Mozaffarian
Journal:  Circulation       Date:  2016-01-12       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.